Mechanics Financial Corp Biogen Inc. Transaction History

Mechanics Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	SELL	$194.69 - $268.46 $97,345 - $134,230	-500 Reduced 90.91%	50 $13,000
Q2 2022 Aug 02, 2022	SELL	$187.54 - $223.02 $1,875 - $2,230	-10 Reduced 1.79%	550 $112,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $38,754 - $48,828	-200 Reduced 26.32%	560 $118,000
Q4 2021 May 13, 2022	BUY	$223.92 - $287.77 $170,179 - $218,705	760 New	760 $182,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mechanics Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mechanics Financial Corp with notifications on news.